卢克索利提尼布相互作用对JAK2 JH1域动态的影响
Hong Nhung Vu1, Ragousandirane Radjasandirane1, Julien Diharce1
1Université Paris Cité and Université de la Réunion, INSERM, EFS, BIGR U1134, DSIMB Bioinformatics Team, F-75015 Paris, France.
International journal of molecular sciences
|May 7, 2025
概括
像Ruxolitinib这样的Janus酶2 (JAK2) 抑制剂对于治疗骨髓增殖性瘤至关重要. 分子动力学模拟显示,鲁克索利提尼布稳定了JAK2 JH1域,抑制了它的活性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 简氏激酶2 (JAK2) 是细胞因子信号传递的关键媒介.
- JAK2突变,特别是V617F,与骨髓增殖性瘤 (MPN) 密切相关,如真多细胞血症 (PV) 和基本血小板血 (ET).
- 异常的JAK2活性也在各种免疫系统疾病中起作用.
研究的目的:
- 研究JAK2 JH1域在不同功能状态下的分子动力学.
- 阐明Ruxolitinib,一个JAK2抑制剂,影响JH1域的动态的机制.
- 了解蛋白质动态在调节JAK2激活中的作用.
主要方法:
- 利用分子动力学 (MD) 模拟来分析JAK2 JH1域.
- 模拟了四个不同的状态:apo JH1,化JH1,Ruxolitinib的JH1和Ruxolitinib的化JH1.
- 量化域灵活性和结构变化.
主要成果:
- 卢克索利提尼布结合诱导了JH1域中的动态行为,类似于其非活性构造.
- 与JH1.1的活性酸化形式相比,Ruxolitinib的存在导致了较不灵活的状态.
- 酸化增加了JH1域的灵活性,与其活性状态相一致.
结论:
- 鲁克索利提尼布通过改变JAK2 JH1域的动态格局来发挥其抑制作用.
- 蛋白质动态对于调节JAK2.2的激活状态至关重要.
- 这项研究为Ruxolitinib等JAK2抑制剂的作用机制提供了分子洞察力.
相关概念视频
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
Protein-Drug Binding: Mechanism and Kinetics
151
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
151
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Receptor Tyrosine Kinases
11.8K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
11.8K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


